Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS

Todd Neale

December 01, 2022

News Daily News

Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms: VITAL

Michael O'Riordan

November 25, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Shelley Wood

August 27, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan

May 26, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Daily News

Statin Use, at Any Dose, Not Linked to Excess Dementia Risk in FH

Yael L. Maxwell

April 22, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

Todd Neale

February 10, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Daily News

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

Todd Neale

January 11, 2022

Advertisement

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS

Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms: VITAL

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

CV Care Around Noncardiac Surgery: New ESC Guidelines

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

June 2022 News Roundup

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Statin Use, at Any Dose, Not Linked to Excess Dementia Risk in FH

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

More Evidence Links Breast Arterial Calcification and CVD Risk

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content